Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Investor Presentations

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

JP Equity Research Report

Investor Presentations 2022, News & Announcements 2022, Research Notes 2022By PharmAustJuly 22, 2022

JP Equity Research Note – July 2022

Read more

Epichem OHD E-Waste Project – Feb 2022 Presentation to Department of Jobs, Tourism, Science and Innovation

Investor Presentations 2022By PharmAustFebruary 16, 2022

Epichem JTSI e-waste Presentation Final

Read more

Epichem Corporate Presentation July 2020

Investor Presentations 2020By PharmAustJuly 2, 2020

Epichem Pty Ltd Corporate Presentation 2020 Final

Read more

PharmAust Shareholder Update Presentation June 2020

Investor Presentations 2020By PharmAustJuly 2, 2020

PAA PRESENTATION JUN 2020 RA FINAL (1)

Read more

Pitt Street Research Life Science Conference: Investor Presentation

Investor Presentations 2019, News & Announcements 2019By PharmAustNovember 28, 2019

191128_Investor Presentation

Read more

Investor Roadshow Presentation September 2019

Investor Presentations 2019, News & Announcements 2019By PharmAustSeptember 9, 2019

190909_Investor Roadshow Presentation September 2019

Read more

July 25 Investor Presentation

Investor Presentations 2019, News & Announcements 2019By PharmAustJuly 26, 2019

190725_PAA PRESENTATION 25 JULY 2019

Read more

Investor Presentation (August)

August 31, 2017

Investor Presentation (May)

May 10, 2017

PharmAust AGM presentation

November 10, 2016

PharmAust Investor Presentation – June 2016

August 10, 2016

USA Roadshow Presentation – January 2016

January 15, 2016

PharmAust AGM Presentation 2015

October 27, 2015

EGM Shareholder Presentation

May 26, 2015

PharmAust Shareholder Presentation – March 2015

March 15, 2015
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
28 Sep

$PAA/@PharmAust has been featured in the inaugural @Stockhead Health & Biotech Investor Guide, titled “The biotech investments turning health into newfound wealth”. You will find our profile on page 39

Stockhead @StockheadAU

The biotech investments turning health into newfound wealth. Check out Stockhead's Investor Guide on Health & Biotech FY2023 https://bit.ly/3Ce2fsI

Reply on Twitter 1575270094623584257 Retweet on Twitter 1575270094623584257 3 Like on Twitter 1575270094623584257 10 Twitter 1575270094623584257
Load More
Copyright © 2022 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top